Emergency Department Screening Detects Prediabetes, Type 2 Diabetes
Only 25% of patients who were identified self-reported having been diagnosed with prediabetes or type 2 diabetes.
Endocrinology Information Center
Top January 2023 FDA Approvals
January FDA approvals include treatments for mood disorders, pertussis in infants, Alzheimer disease, and type 2 diabetes.
Total Nitrites Consumption Tied to Higher Type 2 Diabetes Risk
Total nitrates consumption increases a person’s risk of developing type 2 diabetes.
Rybelsus Now First-Line Option for Type 2 Diabetes Following Label Update
Rybelsus is a glucagon-like peptide receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
AAP Issues Guidelines for Children With Overweight, Obesity
Weight loss pharmacotherapy recommended as adjunct to health behavior and lifestyle treatment in children 12 years and older with obesity.
California Attorney General Sues Drugmakers Over Inflated Insulin Prices
California Attorney General Rob Bonta is taking 3 major drugmakers and 3 distributors to court, alleging the companies illegally raised prices at the expense of diabetes patients.
Symptoms in Late Reproductive Years Similar to Menopause
Authors say findings could help with culturally competent guidance about menopause.
Semaglutide Plus Lifestyle Intervention Beneficial in Adolescents With Obesity
Investigators sought to evaluate the effect of subcutaneous semaglutide therapy for treatment of obesity in adolescents.
Layered Approach Recommended for Patients With Diabetes, CKD
Layered approach involves initially combining lifestyle interventions, self-management, and first-line pharmacotherapy.
Top December 2022 FDA Approvals
December FDA approvals include treatments for weight loss in adolescents, major depressive disorder, lung cancer detection, metastatic non-small cell lung cancer, multiple sclerosis, and lymphoma.
ACP Recommends Bisphosphonates for Initial Treatment of Osteoporosis
The American College of Physicians updated its 2017 guideline on pharmacologic treatment of osteoporosis or low bone mass to prevent fractures in adults.
Best Diets According to the Experts: 2023 Rankings Revealed
A 33 person panel of physicians, registered dietitian nutritionists, and nutritional epidemiologists assessed 24 diets to come up with the final results.
Wegovy Gains Approval for Treating Obesity in Adolescents
Wegovy contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist.
Risk for Type 2 Diabetes Reduced With Higher Daily Step Count
Hazard of incident diabetes reduced by 44% in adjusted models comparing average daily step count of 10,700 to 6000.
Not All Children With Type 2 Diabetes Have Obesity
Meta-analysis results show the prevalence of obesity among children with type 2 diabetes.
CDC Extends Growth Charts to Monitor Severe Obesity in Children, Adolescents
Extended method uses additional data from 1999 to 2016 NHANES, rather than extrapolation; improves characterization of extremely high BMI in children
2023 Standards of Care in Diabetes Released
ADA’s Dr Gabbay discusses the top changes to the Standards of Care in Diabetes—2023
SGLT2 Use Before COVID-19 May Reduce Adverse Outcomes in Patients With Diabetes
SGLT2 inhibitors are associated with lowest probability for adverse outcomes followed by GPL1 receptor agonists and metformin
New Guideline on Diabetes-Related Hypoglycemia Management Released
Endocrine Society Clinical Practice Guideline examines better ways to manage hypoglycemia in people with diabetes.
Does Obesity Have an Effect on Patients With IBD Receiving Biologic Treatments?
Researchers examined the association between obesity and risk for surgical procedures, hospitalization, and serious infections in patients with IBD treated with biologics.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Endocrinology Information Center
Loading... 
Loading...